IQVIA Holdings Inc (IQV)
NYSE · Healthcare · Diagnostics & Research
IQVIA Holdings Inc is a Healthcare company with a market capitalization of $39.22B and a trailing P/E ratio of 28.9.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | July 28, 2026 | $2.75 | $2.72 | +1.1% |
| Q1 2026 | May 5, 2026 | $2.90 | $2.82 | +2.8% |
| Q4 2025 | February 5, 2026 | $3.42 | $3.40 | +0.6% |
| Q3 2025 | October 28, 2025 | $3.00 | $2.98 | +0.7% |
| Q2 2025 | July 22, 2025 | $2.81 | $2.77 | +1.4% |
| Q1 2025 | May 6, 2025 | $2.70 | $2.63 | +2.7% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 5,260,010 | 3.10% | 4.2 | +5.7% |
| June 30, 2026 | 4,977,929 | 2.93% | 2.7 | -1.0% |
| June 15, 2026 | 5,029,629 | 2.96% | 3.5 | +2.8% |
| May 29, 2026 | 4,893,728 | 2.88% | 2.6 | -0.7% |
| May 15, 2026 | 4,927,846 | 2.90% | 2.5 | -0.6% |
| April 30, 2026 | 4,957,411 | 2.88% | 3.2 | +3.2% |
| April 15, 2026 | 4,805,253 | 2.80% | 3.7 | +6.4% |
| March 31, 2026 | 4,514,586 | 2.63% | 2.9 | +7.3% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is IQVIA Holdings Inc's market cap?
As of August 13, 2026, IQVIA Holdings Inc (IQV) has a market capitalization of $39.22B.
What is IQVIA Holdings Inc's P/E ratio?
IQVIA Holdings Inc trades at a trailing price-to-earnings (P/E) ratio of 28.9. Its forward P/E is 18.0.
Does IQVIA Holdings Inc pay a dividend?
IQVIA Holdings Inc does not currently pay a dividend.
What sector is IQV in?
IQVIA Holdings Inc is in the Healthcare sector, specifically the Diagnostics & Research industry.
What is IQVIA Holdings Inc's short interest?
As of the July 15, 2026 FINRA settlement, 5,260,010 IQV shares were sold short, or 3.10% of shares outstanding. Days to cover: 4.2. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was IQVIA Holdings Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), IQVIA Holdings Inc reported revenue of $16.31B and net income of $1.36B.
Ask your own questions about IQV
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.